BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32439286)

  • 1. At-line N-linked glycan profiling for monoclonal antibodies with advanced sample preparation and high-performance liquid chromatography.
    Sha S; Handelman G; Liu N; Xie D; Yoon S
    J Biosci Bioeng; 2020 Sep; 130(3):327-333. PubMed ID: 32439286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycan characterization of the NIST RM monoclonal antibody using a total analytical solution: From sample preparation to data analysis.
    Hilliard M; Alley WR; McManus CA; Yu YQ; Hallinan S; Gebler J; Rudd PM
    MAbs; 2017; 9(8):1349-1359. PubMed ID: 28895795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Preparation of Released N-Glycans for HILIC Analysis Using a Labeling Reagent that Facilitates Sensitive Fluorescence and ESI-MS Detection.
    Lauber MA; Yu YQ; Brousmiche DW; Hua Z; Koza SM; Magnelli P; Guthrie E; Taron CH; Fountain KJ
    Anal Chem; 2015; 87(10):5401-9. PubMed ID: 25927596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid 2AB-UHPLC method based on magnetic beads extraction for N-glycan analysis of recombinant monoclonal antibody.
    Zhang Y; Bu R; Cao Y; Jin J; Meng K; Qiu F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Mar; 1192():123139. PubMed ID: 35139473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of orthogonal chromatographic and lectin-affinity microarray methods for glycan profiling of a therapeutic monoclonal antibody.
    Cook MC; Kaldas SJ; Muradia G; Rosu-Myles M; Kunkel JP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 997():162-78. PubMed ID: 26114652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of an InstantPC-derivatized glycan glucose unit database: A foundation work for high-throughput and high-sensitivity glycomic analysis.
    Xie Y; Butler M
    Glycobiology; 2022 Mar; 32(4):289-303. PubMed ID: 34972858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated High-Throughput Permethylation for Glycosylation Analysis of Biologics Using MALDI-TOF-MS.
    Shubhakar A; Kozak RP; Reiding KR; Royle L; Spencer DI; Fernandes DL; Wuhrer M
    Anal Chem; 2016 Sep; 88(17):8562-9. PubMed ID: 27479043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Biologic Therapeutic N-Glycan Preparation Techniques and Analytical Methods for Facilitating Biomanufacturing Automation.
    Tiwold EK; Gyorgypal A; Chundawat SPS
    J Pharm Sci; 2023 Jun; 112(6):1485-1491. PubMed ID: 36682489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Integrated Solution-Based Rapid Sample Preparation Procedure for the Analysis of N-Glycans From Therapeutic Monoclonal Antibodies.
    Aich U; Liu A; Lakbub J; Mozdzanowski J; Byrne M; Shah N; Galosy S; Patel P; Bam N
    J Pharm Sci; 2016 Mar; 105(3):1221-32. PubMed ID: 26886304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical and enzymatic N-glycan release comparison for N-glycan profiling of monoclonal antibodies expressed in plants.
    Triguero A; Cabrera G; Royle L; Harvey DJ; Rudd PM; Dwek RA; Bardor M; Lerouge P; Cremata JA
    Anal Biochem; 2010 May; 400(2):173-83. PubMed ID: 20109437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of IgG N-glycans employing a microfluidic chip that integrates glycan cleavage, sample purification, LC separation, and MS detection.
    Bynum MA; Yin H; Felts K; Lee YM; Monell CR; Killeen K
    Anal Chem; 2009 Nov; 81(21):8818-25. PubMed ID: 19807107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
    Hodoniczky J; Zheng YZ; James DC
    Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversed-phase liquid-chromatographic mass spectrometric N-glycan analysis of biopharmaceuticals.
    Higel F; Demelbauer U; Seidl A; Friess W; Sörgel F
    Anal Bioanal Chem; 2013 Mar; 405(8):2481-93. PubMed ID: 23371526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
    Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
    MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methods.
    Reusch D; Haberger M; Maier B; Maier M; Kloseck R; Zimmermann B; Hook M; Szabo Z; Tep S; Wegstein J; Alt N; Bulau P; Wuhrer M
    MAbs; 2015; 7(1):167-79. PubMed ID: 25524468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Rapi-Fluor method for glycan profiling and application to commercial antibody drugs.
    Lim MS; So MK; Lim CS; Song DH; Kim JW; Woo J; Ko BJ
    Talanta; 2019 Jun; 198():105-110. PubMed ID: 30876537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation.
    Nováková L; Vlcková H
    Anal Chim Acta; 2009 Dec; 656(1-2):8-35. PubMed ID: 19932811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The criticality of high-resolution N-linked carbohydrate assays and detailed characterization of antibody effector function in the context of biosimilar development.
    Brady LJ; Velayudhan J; Visone DB; Daugherty KC; Bartron JL; Coon M; Cornwall C; Hinckley PJ; Connell-Crowley L
    MAbs; 2015; 7(3):562-70. PubMed ID: 25898160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry and HPLC for carbohydrate analysis.
    Siemiiatkoski J; Lyubarskaya Y
    Dev Biol (Basel); 2005; 122():69-74. PubMed ID: 16375251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-glycan PK Profiling Using a High Sensitivity nanoLCMS Work-Flow with Heavy Stable Isotope Labeled Internal Standard and Application to a Preclinical Study of an IgG1 Biopharmaceutical.
    Higel F; Seidl A; Demelbauer U; Viertlboeck-Schudy M; Koppenburg V; Kronthaler U; Sörgel F; Friess W
    Pharm Res; 2015 Nov; 32(11):3649-59. PubMed ID: 26017302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.